Growth Metrics

Globus Medical (GMED) Cash from Operations (2016 - 2026)

Globus Medical filings provide 15 years of Cash from Operations readings, the most recent being 248587000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 18.18% to 248587000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 753447000.0, a 44.72% increase, with the full-year FY2025 number at 753447000.0, up 44.72% from a year prior.
  • Cash from Operations hit 248587000.0 in Q4 2025 for Globus Medical, roughly flat from 249695000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 249695000.0 in Q3 2025 to a low of 32920000.0 in Q3 2022.
  • Median Cash from Operations over the past 5 years was 63772500.0 (2021), compared with a mean of 98616300.0.
  • Biggest five-year swings in Cash from Operations: plummeted 57.39% in 2022 and later skyrocketed 303.4% in 2024.
  • Globus Medical's Cash from Operations stood at 76253000.0 in 2021, then decreased by 16.1% to 63975000.0 in 2022, then surged by 63.62% to 104674000.0 in 2023, then surged by 100.95% to 210339000.0 in 2024, then increased by 18.18% to 248587000.0 in 2025.
  • The last three reported values for Cash from Operations were 248587000.0 (Q4 2025), 249695000.0 (Q3 2025), and 77865000.0 (Q2 2025) per Business Quant data.